We examined the expression status of FBXO45 [41, 42], SRSF7 [43, 44] and MYBL2 [45], which are not well studied in PCa, in clinical specimens using the Cancer Genome Atlas (TCGA) database. Here, FBXO45 is linked to posterior cortical atrophy.